Home LiteratureArticle Details
PMID: 54923 Published · ppublish English Journal Article

A molecular concept of the properdin pathway.

Medicus RG, Schreiber RD, Götze O, Müller-Eberhard HJ

Abstract

The sequential events of the properdin system were analyzed. Properdin-depleted serum allows the formation of a Factor B- and D-dependent C3 convertase. This enzyme, called the properdin-receptor-forming enzyme, was shown to utilize a novel serum component, the initiating factor. The protein is a beta-globulin in precursor form and is distinct from immunoglobulins. The function of the enzyme is to deposit C3b on the surface of activator particles. Apparently doublets of C3b are required for the formation of the properdin-activating principle. It consists of a complex containing surface-bound C3b and activated Factor B. properdin precursor is activated by binding to this complex without detectable change in molecular weight. The transition of properdin precursor to activated properdin is probably caused by a conformational change. The complex, consisting of bound C3b, properdin, and activated Factor B, represents the enzyme that acts on C5, thereby initiating self-assembly of the membrane attack system. Native C3 is not needed for the function of the enzyme. It is disassembled by soluble C3 or C3b and its formation is under the control of the properdin-receptor-destroying enzyme, which may be identical with the C3b inactivator.

MeSH Terms
Beta-Globulins/metabolism Complement C3/metabolism Complement C5/metabolism Complement System Proteins/metabolism Models, Biological Properdin/metabolism
Chemicals
Beta-Globulins Complement C3 Complement C5 Properdin Complement System Proteins
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Medicus R G
Schreiber R D
Götze O
Müller-Eberhard H J
References (19)
19 references, click to expand
  1. Properties of highly purified human properdin.
    J Immunol. 1968 Jan;100(1):142-58 PMID: 4169693
  2. C3 proactivator convertase and its mode of action.
    J Exp Med. 1972 Apr 1;135(4):1003-8 PMID: 4111773
  3. A serum factor in chronic hypocomplementemic hephritis distinct from immunoglobulins and activating the alternate pathway of complement.
    J Exp Med. 1974 May 1;139(5):1249-61 PMID: 4207623
  4. The alternate pathway of complement activation. The role of C3 and its inactivator (KAF).
    Immunology. 1973 Feb;24(2):259-75 PMID: 4632688
  5. Alternate complement pathway: factors involved in cobra venom factor (CoVF) activation of the third component of complement (C3).
    J Immunol. 1973 Jan;110(1):128-38 PMID: 4734384
  6. The membrane attack mechanism of complement. Isolation and subunit composition of the C5b-9 complex.
    J Exp Med. 1975 Apr 1;141(4):724-35 PMID: 47885
  7. The role of properdin in the alternate pathway of complement activation.
    J Exp Med. 1974 Jan 1;139(1):44-57 PMID: 4808709
  8. The demonstration in human serum of "conglutinogen-activating factor" and its effect on the third component of complement.
    J Immunol. 1968 Apr;100(4):691-8 PMID: 5645214
  9. Formation and functional significance of a molecular complex derived from the second and the fourth component of human complement.
    J Exp Med. 1967 Feb 1;125(2):359-80 PMID: 6019133
  10. Third component of complement (C3): structural properties in relation to functions.
    Proc Natl Acad Sci U S A. 1975 Jun;72(6):1989-93 PMID: 1056006
  11. Properdin: initiation of alternative complement pathway.
    Proc Natl Acad Sci U S A. 1975 Aug;72(8):3220-4 PMID: 1059108
  12. Immunologic injury of cultured cells infected with measles virus. I. role of IfG antibody and the alternative complement pathway.
    J Exp Med. 1975 Apr 1;141(4):761-74 PMID: 1092789
  13. Complete absence of the third component of complement in man.
    J Clin Invest. 1975 Sep;56(3):703-10 PMID: 1159084
  14. Properdin- and nephritic factor-dependent C3 convertases: requirement of native C3 for enzyme formation and the function of bound C3b as properdin receptor.
    J Exp Med. 1975 Sep 1;142(3):760-72 PMID: 1165475
  15. Properdin: binding to C3b and stabilization of the C3b-dependent C3 convertase.
    J Exp Med. 1975 Oct 1;142(4):856-63 PMID: 1185108
  16. Formation and composition of the C3 activating enzyme complex of the properdin system. Sequential assembly of its components on solid-phase trypsin-agarose.
    Z Immunitatsforsch Exp Klin Immunol. 1975 Jul;149(5):440-55 PMID: 126576
  17. The properdin system and immunity. I. Demonstration and isolation of a new serum protein, properdin, and its role in immune phenomena.
    Science. 1954 Aug 20;120(3112):279-85 PMID: 13186838
  18. The C3-activator system: an alternate pathway of complement activation.
    J Exp Med. 1971 Sep 1;134(3 Pt 2):90s-108s PMID: 4105810
  19. Formation of a hemolytically active cellular intermediate by the interaction between properdin factors B and D and the activated third component of complement.
    J Exp Med. 1973 Dec 1;138(6):1305-13 PMID: 4202731
Article Info
Journal
Proceedings of the National Academy of Sciences of the United States of America
Abbr.
Proc Natl Acad Sci U S A
ISSN
0027-8424
Published
1976-02-00
Pages
612-6
Language
English
Region
United States
NLM ID
7505876
PMCID
PMC335961
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]